For: | Brzdęk M, Zarębska-Michaluk D, Invernizzi F, Cilla M, Dobrowolska K, Flisiak R. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C. World J Gastroenterol 2023; 29(6): 949-966 [PMID: 36844142 DOI: 10.3748/wjg.v29.i6.949] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i6/949.htm |
Number | Citing Articles |
1 |
Jiyoung Lee, J.-H. James Ou. HCV-induced autophagy and innate immunity. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1305157
|
2 |
Muhammad Shahab, Abbas Khan, Salman Ali Khan, Guojun Zheng. Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3/4A protease: Structural and molecular simulation-based insights. International Journal of Biological Macromolecules 2024; 267: 131629 doi: 10.1016/j.ijbiomac.2024.131629
|
3 |
Krystyna Dobrowolska, Michał Brzdęk, Piotr Rzymski, Robert Flisiak, Małgorzata Pawłowska, Jakub Janczura, Kinga Brzdęk, Dorota Zarębska-Michaluk. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals. Expert Opinion on Pharmacotherapy 2024; 25(7): 833 doi: 10.1080/14656566.2024.2358139
|
4 |
Michał BRZDĘK, Dorota ZARĘBSKA-MICHALUK, Krzysztof TOMASIEWICZ, Magdalena TUDRUJEK-ZDUNEK, Beata LORENC, Włodzimierz MAZUR, Hanna BERAK, Justyna JANOCHA-LITWIN, Jakub KLAPACZYŃSKI, Marek SITKO, Ewa JANCZEWSKA, Dorota DYBOWSKA, Anna PARFIENIUK-KOWERDA, Anna PIEKARSKA, Jerzy JAROSZEWICZ, Robert FLISIAK. Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people. Minerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09238-3
|
5 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
6 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Michał Kukla, Justyna Janocha-Litwin, Dorota Dybowska, Ewa Janczewska, Beata Lorenc, Hanna Berak, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Jakub Klapaczyński, Anna Piekarska, Marek Sitko, Łukasz Laurans, Anna Parfieniuk-Kowerda, Robert Flisiak. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices. Pharmacological Reports 2024; 76(5): 1114 doi: 10.1007/s43440-024-00639-9
|
7 |
Krystyna Dobrowolska, Małgorzata Pawłowska, Dorota Zarębska‐Michaluk, Piotr Rzymski, Ewa Janczewska, Magdalena Tudrujek‐Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczyński, Beata Lorenc, Justyna Janocha‐Litwin, Anna Parfieniuk‐Kowerda, Dorota Dybowska, Anna Piekarska, Rafał Krygier, Beata Dobracka, Jerzy Jaroszewicz, Robert Flisiak. Direct‐acting antivirals in women of reproductive age infected with hepatitis C virus. Journal of Viral Hepatitis 2024; 31(6): 309 doi: 10.1111/jvh.13936
|
8 |
Robert Flisiak, Dorota Zarębska‐Michaluk, Ewa Janczewska, Anna Parfieniuk‐Kowerda, Włodzimierz Mazur, Marek Sitko, Justyna Janocha‐Litwin, Rafał Krygier, Beata Lorenc, Anna Piekarska, Barbara Sobala‐Szczygieł, Krystyna Dobrowolska, Łukasz Socha, Jerzy Jaroszewicz. Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment. Journal of Viral Hepatitis 2024; doi: 10.1111/jvh.13991
|
9 |
Ahmed B. Zaid, Shimaa K. Almady, Samah M. Awad, Mona G. Elabd, Sara A. Saied, AbdulRahman A Saied, Alshimaa M Elmalawany. Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells. Current Research in Translational Medicine 2024; 72(3): 103443 doi: 10.1016/j.retram.2024.103443
|
10 |
Piotr Rzymski, Michał Brzdęk, Krystyna Dobrowolska, Barbara Poniedziałek, Aleksandra Murawska-Ochab, Dorota Zarębska-Michaluk, Robert Flisiak. Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection. Viruses 2024; 16(9): 1386 doi: 10.3390/v16091386
|